Table 2: Reasons for study exclusion.
Exclusion group |
Reason for exclusion |
# Of References |
Duplicate references (774) |
Duplicate studies |
774 |
Irrelevant exposure (260) |
Non-quinolone related studies |
260 |
Unavailable full-text (6) |
Reference could not be retrieved |
6 |
Irrelevant population (41) |
Current or prior liver impairment |
41 |
Non-original studies (971) |
Non-original studies |
971 |
Irrelevant study design (1,190) |
Quinolone combined with other drugs |
284 |
Cross-over trial |
194 |
|
No results available |
167 |
|
Trial with multiple arms |
149 |
|
Quinolone in a topical formulation |
126 |
|
Observational study |
106 |
|
Trial with a single arm |
96 |
|
Quinolones on multiple arms |
68 |
|
Irrelevant publication type (179) |
Review article |
89 |
Case report/case series |
73 |
|
Letter/commentary |
7 |
|
Not a clinical trial |
6 |
|
Report |
3 |
|
Conference abstract |
1 |
|
Eligible trials |
Eligible clinical trials with no reporting on acute liver failure |
137 |